Fiche centre
UCLA Medical Center
Los Angeles — United States
Essais liés7clinical trials
VilleLos Angeleslocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT03417388
Essais cliniques associés
7| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| High dose potent statin | Maladie coronarienne | Phase 4 | NCT03417388 | WARRIOR — Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD | ACTIVE_NOT_RECRUITING |
| Resamirigene bilparvovec | Myopathies | Phase 2/3 | NCT03199469 | ASPIRO — A Study of AT132 in Young Children With X-Linked Myotubular Myopathy (XLMTM) | ACTIVE_NOT_RECRUITING |
| PF-06939926 | Myopathies | Phase 3 | NCT04281485 | Study to Evaluate the Safety and Efficacy of PF-06939926 for the Treatment of Duchenne Muscular Dystrophy | ACTIVE_NOT_RECRUITING |
| Sevasemten 10 mg | Myopathies | Phase 2 | NCT05291091 | Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON) | COMPLETED |
| Sevasemten | Myopathies | Phase 2 | NCT06066580 | MESA — Open-Label Extension of EDG-5506 in Participants With Becker Muscular Dystrophy | ENROLLING_BY_INVITATION |
| Sevasemten Dose 1 | Myopathies | Phase 2 | NCT06100887 | FOX — Phase 2 Study of EDG-5506 in Children and Adolescents With Duchenne Muscular Dystrophy Previously Treated With Gene Therapy | ACTIVE_NOT_RECRUITING |
| Flow Detection System | Migraine | Phase 3 | NCT01773252 | PFO Detection — Right to Left Cardiac Shunt Detection | TERMINATED |